Zimmer Biomet Holdings, Inc. (ZBH) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated February 10, 2026, reports the financial results for Zimmer Biomet Holdings, Inc. for the quarter and full year ended December 31, 2025. The filing incorporates by reference a press release (Exhibit 99.1) containing the detailed operational and financial data.
Key Financial Metrics
The provided text serves as a cover report and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus prior periods. Investors must refer to the incorporated press release for comparative analysis of the quarter and year ended December 31, 2025.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, risk factors, and contingencies are contained within the referenced press release (Exhibit 99.1). The 8-K text itself does not disclose specific outlook figures or unusual items.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and EPS figures for Q4 and FY 2025.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for updated full-year 2026 guidance provided in the press release.
- Confirm details on the company's outstanding debt instruments listed in the filing (2.425% Notes due 2026, 1.164% Notes due 2027, 3.518% Notes due 2032).
- Assess any non-GAAP reconciliations or unusual items disclosed in the press release.